40 Under Forty 2019 nomination for Georgia Bio’s Maria Thacker-Goethe

We are delighted to announce that Maria Thacker-Goethe, President & CEO of Georgia Bio and Executive Director of Georgia Global Health Alliance, has been selected by the Atlanta Business Chronicle as a 40 Under Forty 2019 honoree. More than 400 nominations were submitted this year and her professional and personal accomplishments secured her place alongside other prominent Atlanta leaders.

Below are a few of her many accomplishments:

Named the President & CEO of Georgia Bio in 2019 and affiliated for 13 years
Became the launching Executive Director for the Georgia Global Health Alliance in 2016
Secured state funding to expand the Georgia BioEd Institute rural teacher training initiatives
Leading health ecosystem collaboration and expansion through Global Health ATL
Serves on the boards for CJD Foundation, Southeast BIO, Southeast Medical Device Association, and Coalition of State Bioscience Institutes
2019 Recipient of the Metro Atlanta Chamber Phoenix Award
2009 Recipient of the Power 30 Under 30 Awards
10 years with the Junior League of Atlanta: Chair for the La Amistad Estrellitas and Wellspring Living programs

Maria is passionate about her work and community – all while making time for her 2-year old daughter Cecilia and her husband, Patrick. We thank her for championing the efforts to make Georgia’s Life Sciences and Public Health industries known throughout the state, nationally and globally.The honorees will be celebrated at an evening awards event on Nov. 7, 2019, at The Fairmont, 1429 Fairmont Ave. NW, in Atlanta.

The post 40 Under Forty 2019 nomination for Georgia Bio’s Maria Thacker-Goethe appeared first on Georgia Bio.

< Older Post

Newer Post >

September GBG Report Now Available – Federal Funding Insights for Georgia Life Sciences Members

September 11, 2025

Members are invited to join G2G’s Monthly GBG Reporting Service Webinar on September 18, 2025 . The first portion ( 12:00–12:30 PM ET ) is free and open to all, offering a high-level overview of current federal funding trends. The second half ( 12:30–1:00 PM ET ) is a premium consultation available only to Georgia Life Sciences members, offering direct access to G2G’s expert team—who have helped secure over $550 million in non-dilutive government funding since 2007. Register here: https://www.g2gconsulting.com/event/non-dilutive-funding-g2gs-monthly-gbg-reporting-service-webinar-14-3/2025-09-18/ Key opportunities this month include DARPA’s Expedited Research Innovation System for CBRN threat defense technologies, BARDA’s I-CREATE diagnostic funding and VANGUARD biomanufacturing tools development (each offering up to $200,000), NIAID tuberculosis and influenza research units (up to $1.5–$2.5 million annually), DoD’s $4 million Advanced Medical Monitor development through MTEC, and multiple SBIR opportunities for sensors and field-deployable diagnostics (up to $209,575 for Phase I awards). The September GBG report highlights 13 immunology and infectious disease opportunities, 10 cognitive and brain health programs, and several biotechnology and biomanufacturing initiatives across federal agencies including the Army, ARPA-H, BARDA, and NSF. Georgia Life Sciences members can access the complete 29-page report with detailed deadlines and eligibility requirements [insert link or portal instructions here]. GLS members can access the full 29-page report with deadlines and submission details by logging into your member portal.